Warenkorb

0.00
HPLC-getestetCOA jede ChargeEU-VersandSEPA · sichere ZahlungNur für Forschungszwecke
PEPTIQA BIOTECHSemax10 mgPurity 98.5% · RUO

Excellent

Ocena 4.8 / 5 — zgodnja ocena kakovosti

Peptiqa Reviews

Zgodnja ocena kakovosti — po prvem verified nakupu lahko kupci objavijo mnenje.

Semax

10 mg98.5% purityLot #SEMAX-2026-001

Art.-Nr. der gewählten Abmessung: PEP-SEMAX-10MG

Semax is a synthetic nootropic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH 4-10), enhanced with a Pro-Gly-Pro sequence to improve both stability and bioavailability. Originally developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, Semax has been approved in Russia and Ukraine as a prescription medication for stroke rehabilitation, cognitive dysfunction, and peptic ulcer disease. Its primary mechanism centers on the substantial upregulation of BDNF (Brain-Derived Neurotrophic Factor), a critical protein involved in neuronal growth, survival, and synaptic plasticity. Research published in Neuroscience Letters has shown that Semax can increase BDNF mRNA expression by up to six-fold, contributing to enhanced memory formation, cognitive performance, and neuroprotection.
€70.76inkl. MwSt.
auf Lager (40)

Mengenpreise

MengeStückpreisErsparnis
1 vial70.76
3 vials (−7%)65.88−7%
5 vials (−12%)62.22−12%
Nakup & zberi 58 točk!

Ocene in mnenja

Prijavite se in ocenite izdelek po prejetem naročilu. Anmelden

Analysezertifikat

Lab-verifiziert
COA vor dem Kauf ansehen — Transparenz garantiert
Forschungsprofil

Semaxwissenschaftliches Profil

Inhalt dient Bildungs- und Forschungszwecken. Research Use Only.

  • Semax is a synthetic nootropic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH 4-10), enhanced with a Pro-Gly-Pro sequence to improve both stability and bioavailability. Originally developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, Semax has been approved in Russia and Ukraine as a prescription medication for stroke rehabilitation, cognitive dysfunction, and peptic ulcer disease.
  • Its primary mechanism centers on the substantial upregulation of BDNF (Brain-Derived Neurotrophic Factor), a critical protein involved in neuronal growth, survival, and synaptic plasticity. Research published in Neuroscience Letters has shown that Semax can increase BDNF mRNA expression by up to six-fold, contributing to enhanced memory formation, cognitive performance, and neuroprotection.

Mehr aus Nootropiki

Diese Seite verwendet Cookies

Accept